Evidence map›Paper›PMID 40260121›Full record

ArticleNeuroscience of consciousness2025

Exploring 5-MeO-DMT as a pharmacological model for deconstructed consciousness.

Christopher Timmermann, James W Sanders, David Reydellet, Tommaso Barba, Lisa X Luan, Óscar Soto Angona, Genís Ona, Giancarlo Allocca, Carl H Smith, Zachary G Daily and 9 more

Abstract read
In one paragraph

Article in Neuroscience of consciousness, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Illuminating consciousness.Frontiers in psychology · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Christopher TimmermannDMT Research Group, Centre for Psychedelic Research, Department of Brain Sciences, Imperial College London, London W12 0NN, UK.ORCID https://orcid.org/0000-0002-2281-377X
James W SandersDMT Research Group, Centre for Psychedelic Research, Department of Brain Sciences, Imperial College London, London W12 0NN, UK.
David ReydelletDMT Research Group, Centre for Psychedelic Research, Department of Brain Sciences, Imperial College London, London W12 0NN, UK.
Tommaso BarbaDMT Research Group, Centre for Psychedelic Research, Department of Brain Sciences, Imperial College London, London W12 0NN, UK.
Lisa X LuanDMT Research Group, Centre for Psychedelic Research, Department of Brain Sciences, Imperial College London, London W12 0NN, UK.
Óscar Soto AngonaParc Sanitari Sant Joan de Dèu, Barcelona 08830, Spain.
Genís OnaParc Sanitari Sant Joan de Dèu, Barcelona 08830, Spain.
Giancarlo AlloccaFlorey Department of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria 3052, Australia.
Carl H SmithDepartment of Media, School of the Arts and Creative Industries, University of East London, London, E16 2RD, UK.
Zachary G DailyDMT Research Group, Centre for Psychedelic Research, Department of Brain Sciences, Imperial College London, London W12 0NN, UK.
Natasha L MasonDepartment of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, 6229, the Netherlands.
Lilian Kloft-HellerDepartment of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, 6229, the Netherlands.
Martin KucharForensic Laboratory of Biologically Active Substances, Department of Chemistry of Natural Compounds, University of Chemistry and Technology, Prague 166 28, Czech Republic.
Lucie JaneckovaForensic Laboratory of Biologically Active Substances, Department of Chemistry of Natural Compounds, University of Chemistry and Technology, Prague 166 28, Czech Republic.
Tomas PalenicekPsychedelic Research Center, National Institute of Mental Health, Klecany 250 67, Czech Republic.
David ErritzoeDMT Research Group, Centre for Psychedelic Research, Department of Brain Sciences, Imperial College London, London W12 0NN, UK.
Johannes G RamaekersDepartment of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, 6229, the Netherlands.
Robin L Carhart-HarrisDMT Research Group, Centre for Psychedelic Research, Department of Brain Sciences, Imperial College London, London W12 0NN, UK.
Malin Vedøy UthaugDMT Research Group, Centre for Psychedelic Research, Department of Brain Sciences, Imperial College London, London W12 0NN, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

5-MeO-DMT is a short-acting psychedelic that is anecdotally reported to induce a radical disruption of the self and a paradoxical quality of aroused, waking awareness that is nevertheless devoid of any specific perceptual contents. Here, we conducted an exploratory observational study of the phenomenological and neuronal effects of this compound. We collected micro-phenomenological interviews, psychometric questionnaires, and electroencephalography (EEG) in naturalistic ceremonial settings where 5-MeO-DMT was ingested. Results revealed that the 5-MeO-DMT experience followed a dynamic progression that-only in the most extreme cases-manifested as a complete absence of self-experience and other phenomenal content with preserved awareness. Furthermore, visual imagery, bodily self-disruption, narrative self-disruption, and reduced phenomenal distinctions occurred in a variable fashion. EEG analyses revealed the 5-MeO-DMT experience was characterised by (global) alpha and (posterior) beta power reductions, implying a mode of brain functioning where top-down models are inhibited. Our preliminary phenomenological findings confirm the potential utility of 5-MeO-DMT as a pharmacological model for deconstructed consciousness while noting the limitations of employing retrospective questionnaires for this purpose. Considering the exploratory nature of this study and its limitations inherent to its naturalistic nature, further research employing real-time experience sampling and phenomenologically trained participants in controlled environments could expand our findings to meaningfully inform the potential of this tool for the scientific study of consciousness.

Indexed as

awarenessEEGneurophenomenologypsychedelicselfserotonin

Identifiers

PMID40260121
PMCPMC12010161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.